BG
IMGN

BlackRock Group’s Immunogen Inc IMGN Stock Holding History

BlackRock Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$212K Buy
103,919
+5,827
+6% +$11.7K ﹤0.01% 2641
2016
Q3 		$263K Sell
98,092
-24,191
-20% -$70.3K ﹤0.01% 2534
2016
Q2 		$376K Buy
122,283
+25,855
+27% +$162K ﹤0.01% 2361
2016
Q1 		$821K Buy
96,428
+9,496
+11% +$80.3K ﹤0.01% 2032
2015
Q4 		$1.18M Sell
86,932
-1,113
-1% -$13.7K ﹤0.01% 1788
2015
Q3 		$845K Buy
88,045
+4,162
+5% +$60.8K ﹤0.01% 1979
2015
Q2 		$1.21M Buy
83,883
+6,927
+9% +$76.1K ﹤0.01% 1853
2015
Q1 		$688K Buy
76,956
+5,287
+7% +$38.3K ﹤0.01% 2056
2014
Q4 		$437K Buy
71,669
+7,000
+11% +$64K ﹤0.01% 2280
2014
Q3 		$684K Buy
64,669
+16,192
+33% +$183K ﹤0.01% 2015
2014
Q2 		$575K Sell
48,477
-22,484
-32% -$282K ﹤0.01% 2146
2014
Q1 		$1.06M Buy
70,961
+12,431
+21% +$196K ﹤0.01% 1965
2013
Q4 		$859K Buy
58,530
+4,108
+8% +$63.1K ﹤0.01% 2035
2013
Q3 		$926K Buy
54,422
+1,759
+3% +$30.9K ﹤0.01% 1952
2013
Q2 		$874K Buy
+52,663
New +$853K ﹤0.01% 1857

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock Group's IMGN Position: Q4 2016 in Review

BlackRock Group increased its Immunogen Inc (IMGN) stake by 5.9% in Q4 2016, buying an estimated $11.7K and bringing the position to 103,919 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #2641.

BlackRock Group first reported a position in IMGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.21M in Q2 2015. 156 funds tracked by Wall St. Rank hold IMGN as of Q4 2016.

  • BlackRock Group held 103,919 shares of Immunogen Inc worth $212K as of Q4 2016.
  • BlackRock Group bought 5,827 Immunogen Inc shares in Q4 2016, an estimated $11.7K.
  • Immunogen Inc made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2641 holding.
  • BlackRock Group first reported a position in Immunogen Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Immunogen Inc position peaked at $1.21M in Q2 2015.
  • 156 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.